October 22, 2013
Baxter International Inc. on Tuesday hit HQ Specialty Pharma Corp. with a lawsuit in New Jersey federal court alleging HQ's proposed generic version of its blood pressure and heart rhythm disorder drug Brevibloc infringes two of its patents.